Watch an on-demand webinar featuring Solomon Banjo, Sr. Analyst, Health IT Research, from the Advisory Board as he shares the latest research, the key forces shaping imaging, and how to position imaging programs for success.
Imaging providers are seeing unprecedented change. Patients are becoming more consumeristic and engaged. It’s changing what they expect from their imaging providers, and how providers engage with them and compete for them.
Resources to meet healthcare needs are becoming more limited. Providers are focusing on opportunities to increase efficiency as reimbursements continue to decline. And there’s an increasing emphasis on linking reimbursement to quality metrics and patient outcomes, jeopardizing operating margins of providers, forcing a reduction in wasteful practices like redundant imaging.
During this on-demand webinar moderated by Mini Peiris, CMO at Ambra Health (formerly known as DICOM Grid), you’ll learn:
Complete the form to watch this informative webinar.
Solomon Banjo, Sr. Analyst, Health IT Research, from the Advisory Board
Solomon Banjo has been a researcher at the Advisory Board Company since 2013. During his tenure with the Imaging Performance Partnership, Solomon has contributed to research on lung cancer screening program creation, outpatient imaging access, technologist productivity, enterprise imaging, and the impaces of regulatory and reimbursement changes on radiology.
Mini Peiris, Ambra Health
Mini Peiris is the CMO of Ambra Health (formerly known as DICOM Grid) and a passionate believer in the end-to-end provider and patient experience. She works closely with Ambra Health’s advisory board of physicians, administrative executives and healthcare IT leaders. Prior to Ambra Health, Mini spent 12+ years at NetSuite Inc. (NYSE: N) as Vice President, Worldwide Marketing and Vice President, Product Management. In these executive leadership roles, she drove NetSuite’s global go-to-market programs and product direction as they grew from early startup in 2002, to successful IPO in 2007, to a $550M+ revenue business in 2014. Mini holds a B.S. in Cellular Molecular Biology from the University of Michigan and began her career as a research scientist at Janssen Pharmaceutica. Connect with Mini or follow @Mini_Peiris